217 results
Page 9 of 11
8-K
EX-99
n1r75md72brc6khg1ejf
10 Oct 06
Theravance Announces Additional Results From Successful Phase 3 Telavancin Complicated Skin and Skin Structure Program
12:00am
424B5
2tdg89xuiz
2 Feb 06
Prospectus supplement for primary offering
12:00am
S-3ASR
EX-10.1
x7j2vjrf1eqhlwl19
30 Jan 06
Automatic shelf registration
12:00am
8-K
EX-99.1
8m8ceht7jxm
30 Jan 06
Regulation FD Disclosure
12:00am
S-3ASR
b5343vkml3hbbi
30 Jan 06
Automatic shelf registration
12:00am
8-K
EX-99.1
52sxr69bjjoofyb5f1
11 Jan 06
LABA Update Conference Call
12:00am
DEF 14A
9xj wtbmtjygprhz6i
12 May 05
Definitive proxy
12:00am
424B3
4frhbh
9 May 05
Prospectus supplement
12:00am
10-K
du5ka s3j
29 Mar 05
Annual report
12:00am
10-Q
EX-4.2
vsm8jdiu46
17 Nov 04
Quarterly report
12:00am